CABOMETYX (cabozantinib) Patient Assistance Program
Don’t let the high cost of brand specialty multi-kinase inhibitor therapy stand between you and the treatment you need. We help eligible patients access Cabometyx (cabozantinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Cabometyx (cabozantinib) is FDA-approved for advanced renal cell carcinoma (alone or in combination with nivolumab), hepatocellular carcinoma in patients previously treated with sorafenib, advanced or metastatic differentiated thyroid cancer that has progressed following prior VEGFR-targeted therapy and is radioactive iodine-refractory, and previously-treated advanced neuroendocrine tumors.
- Without assistance, the retail cost commonly runs approximately $25,000–$30,000 per 30-day supply at the standard 60 mg daily dose.
- Through AffordMyPrescriptions, qualifying patients can access Cabometyx for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Cabometyx available in the U.S. as of 2026.
What Is Cabometyx Prescription Assistance Program?
The Cabometyx Prescription Assistance Program is a manufacturer-sponsored initiative that provides Cabometyx at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for cancer patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Cabometyx costs roughly $25,000–$30,000 per 30-day supply at retail pharmacies. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$29,500.00 | Save ~$29,430/mo |
| CVS Pharmacy | ~$30,000.00 | Save ~$29,930/mo |
| Walmart | ~$26,500.00 | Save ~$26,430/mo |
| Costco | ~$25,800.00 | Save ~$25,730/mo |
| Specialty Pharmacy | ~$26,000.00 | Save ~$25,930/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Cabometyx Prescription Program?
The Patient Assistance Program is free to apply for and provides Cabometyx at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Cabometyx:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $25,000–$30,000 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Cabometyx assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Cabometyx Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Cabometyx:
Cabometyx (cabozantinib) is an oral, targeted multi-kinase inhibitor used to treat several advanced cancers, including renal cell carcinoma (alone or with nivolumab), hepatocellular carcinoma after prior sorafenib, advanced differentiated thyroid cancer that is radioactive iodine-refractory, and previously-treated advanced neuroendocrine tumors. It is taken as one 60 mg tablet by mouth once daily.
How Cabometyx Works:
Cabometyx is a multi-kinase inhibitor that slows cancer progression by blocking several receptors simultaneously, including VEGFR, MET, AXL, and RET. By interrupting tumor blood-vessel formation and cell growth signals at the same time, it targets the pathways that drive tumor invasion and resistance. This broad kinase profile allows it to be effective across multiple cancer types compared to single-target inhibitors.
Form and use:
This medication is taken as a tablet once daily on an empty stomach, either 1 hour before or 2 hours after eating. The standard dose is 60 mg, though it may be reduced to 40 mg when used in combination with nivolumab. Patients should swallow tablets whole and continue treatment until disease progression or unacceptable toxicity occurs, with potential dose adjustments for side effects.
Generic availability:
As of 2026, there is no FDA-approved generic version of Cabometyx available in the United States. While other multi-kinase inhibitors and targeted therapies are approved for similar cancer types, Cabometyx remains a brand-name-only option. Clinical suitability for alternatives depends on a patient’s specific indication, biomarker status, and history of prior treatments.
Warnings:
Cabometyx carries warnings for serious side effects including severe hemorrhage, gastrointestinal perforations, and blood clots. Patients are monitored regularly for hypertension, hand-foot syndrome, diarrhea, and potential damage to the liver, thyroid, or kidneys. Other risks include impaired wound healing and jaw-related bone issues, requiring constant supervision of blood pressure and organ function by an oncology team.
FAQ (Frequently Asked Questions)
How Much Does Cabometyx Cost Without Insurance?
The retail price commonly runs $25,000–$30,000 per 30-day supply at the standard 60 mg daily dose. Through AffordMyPrescriptions, qualifying patients receive Cabometyx at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Cabometyx Taken?
Cabometyx is taken at 60 mg by mouth once daily (or 40 mg in combination with nivolumab) on an empty stomach — at least 1 hour before or 2 hours after a meal. Tablets should be swallowed whole. Take it at roughly the same time each day. Your oncology team may adjust the dose for side effects.
Are There Other Multi-Kinase Inhibitors I Should Know About?
Yes. Other multi-kinase inhibitors include sunitinib, pazopanib, axitinib, lenvatinib, sorafenib, and tivozanib. Each has a slightly different kinase-targeting profile and side-effect profile. Whether one is a better clinical fit depends on the indication, prior treatments, and tolerability. We mention this directly because if a different therapy on a more accessible assistance pathway would work, that may be a better path.
What Side Effects Should I Watch For?
The most common side effects include diarrhea, fatigue, decreased appetite, palmar-plantar erythrodysesthesia (hand-foot syndrome — redness/peeling of palms and soles), high blood pressure, nausea, vomiting, weight loss, constipation, and decreased weight. Tell your oncology team about persistent diarrhea, severe hand or foot pain, severe headache, vision changes, or any unusual symptoms.
Can I Get Cabometyx Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Cabometyx Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — the manufacturer’s copay assistance program if you have commercial insurance, independent oncology foundations such as the PAN Foundation, HealthWell Foundation, Kidney Cancer Association, or Thyroid Cancer Survivors’ Association, or asking your oncology team whether a different multi-kinase inhibitor or targeted therapy would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Cabometyx, our team may be able to help you access assistance programs designed to make brand specialty multi-kinase inhibitor therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.